×
About 14,853 results

ALLMedicine™ Dengue Center

Research & Reviews  5,459 results

Cell strain-derived induced pluripotent stem cell as a genetically controlled approach ...
https://doi.org/10.1128/JVI.01737-21
Journal of Virology; Bifani AM, Tan HC et. al.

Dec 2nd, 2021 - The expansion of the geographical footprint of dengue viruses (DENVs) and their mosquito vectors have affected more than half of the global population, including older adults who appear to show elevated risk of severe dengue. Despite this epidemio...

Dengue during the COVID-19 pandemic.
https://doi.org/10.1093/jtm/taab183
Journal of Travel Medicine; Wilder-Smith A

Dec 2nd, 2021 - Despite COVID-19-related disruptions in controlling dengue, efforts need to be maintained to prevent vector-borne diseases during this pandemic. Although travel restrictions brought a global halt to mobility and therefore also a substantial declin...

Mortality Rates of Severe Dengue Viral Infection Before and After Implementation of a R...
https://doi.org/10.1097/INF.0000000000003411
The Pediatric Infectious Disease Journal; Laoprasopwattana K, Khantee P et. al.

Nov 30th, 2021 - To compare the mortality rate of severe dengue (SD) before and after implementation of a revised SD guideline. Medical records of SD patients aged <15 years hospitalized during 1998-2020 were reviewed. The revised SD guidelines were implemented in...

IL-18: The Forgotten Cytokine in Dengue Immunopathogenesis.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8626198
Journal of Immunology Research; Nanda JD, Ho TS et. al.

Nov 30th, 2021 - Dengue fever is an infection by the dengue virus (DENV) transmitted by vector mosquitoes. It causes many infections in tropical and subtropical countries every year, thus posing a severe disease threat. Cytokine storms, one condition where many pr...

"We Tried to Borrow Money, but No One Helped." Assessing the Three-Delay Model Factors ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8621089
International Journal of Environmental Research and Publi... Ligsay AD, Santos MLB et. al.

Nov 28th, 2021 - Identification of delay barriers to care is essential for an effective and efficient healthcare service delivery. In this study, we described the delay in care among parents of the patients seeking treatment for dengue. We also examined the factor...

see more →

Guidelines  3 results

Dengue and Zika Virus Diagnostic Testing for Patients with a Clinically Compatible Illn...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6581290
MMWR. Recommendations and Reports : Morbidity and Mortali... Sharp TM, Fischer M et. al.

Jun 14th, 2019 - Dengue and Zika viruses are closely related mosquitoborne flaviviruses with similar transmission cycles, distribution throughout the tropics and subtropics, and disease manifestations including fever, rash, myalgia, and arthralgia. For patients wi...

Best practices in dengue surveillance: a report from the Asia-Pacific and Americas Deng...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2982842
PLoS Neglected Tropical Diseases; Beatty ME, Stone A et. al.

Nov 26th, 2010 - Dengue fever is a virus infection that is spread by the Aedes aegypti mosquito and can cause severe disease especially in children. Dengue fever is a major problem in tropical and sub-tropical regions of the world. We invited dengue experts from a...

"Guidelines for the clinical evaluation of dengue vaccines in endemic areas": summary o...
https://doi.org/10.1016/j.vaccine.2008.05.058
Vaccine Edelman R, Hombach J

Jul 4th, 2008 - There is a pressing need for guidelines focused on the clinical evaluation of dengue vaccines in exposed populations, because Phase 1 and 2 clinical trials of dengue vaccines have begun, and Phase 3 field trials may be warranted soon. In response ...

see more →

Drugs  1 results see all →

Clinicaltrials.gov  94 results

HDL Target of CoViD19 ? Analysis on the Caregivers of the Reunion University Hospital
https://clinicaltrials.gov/ct2/show/NCT04384705

Nov 24th, 2021 - Since December 2019, the Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) pandemic has spread around the world. The people most exposed to this virus remain the healthcare personnel who are on the front line in the fight against this p...

Long-Term Safety and Antibody Persistence of TDV and the Impact of a Booster Dose
https://clinicaltrials.gov/ct2/show/NCT03999996

Nov 17th, 2021 - The vaccine tested in this study is Takeda's Tetravalent Dengue Vaccine Candidate (TDV). This study will look at the long-term antibody persistence and safety of Takeda's TDV in healthy adolescents and adults and will assess the impact of a booste...

Prospective Study on the Risks of Dengue Fever for the Fetus.
https://clinicaltrials.gov/ct2/show/NCT04822441

Nov 4th, 2021 - Dengue is the most common arbovirus worldwide (390 million people infected each year) and belongs to the Flavivirus genus of the Flaviviridae family like Zika. Its expansion has been rapid since the last decade with an increase in the number of ca...

Observational Study to Evaluate the Safety of CYD Tetravalent Dengue Vaccine (CYD-TDV) in Pregnant Women and Their Offsprings Inadvertently Exposed During Pregnancy
https://clinicaltrials.gov/ct2/show/NCT04023708

Nov 1st, 2021 - This is a non -interventional (observational) post authorization safety study (PASS): no vaccine will be administered as part of the study. This pregnancy registry study is a combination of a retrospective (outcomes occurred before the start of pa...

Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children
https://clinicaltrials.gov/ct2/show/NCT02948829

Oct 15th, 2021 - The vaccine tested in this study was TDV. This study assessed cellular immune responses and safety up to 3 years post second TDV administration to healthy children aged 4 to 16 years and in dengue endemic regions. The study enrolled 200 participan...

see more →

News  379 results

ACIP Recommends Universal HBV Vaccination for Adults Under 60, Expands Recommendations for Vaccines Against Orthopoxviruses and Ebola
https://www.medscape.com/viewarticle/962310

Nov 4th, 2021 - The Advisory Committee on Immunization Practices (ACIP) of the US Centers for Disease Control and Prevention has unanimously voted to recommend universal hepatitis B (HBV) immunization in all unvaccinated adults aged 59 or younger. The group also ...

First Drug for Dengue Found to Be Effective in Mice; Human Clinical Trials Starting
https://www.medscape.com/viewarticle/960589

Oct 11th, 2021 - Researchers at KU Leuven Rega Institute and Center for Drug Design and Discovery (CD3), Leuven, Belgium, have identified a new target for treating dengue in collaboration with Jannsen Pharmaceutica, NV. As reported in Nature, the antiviral compoun...

Dengue Suspected of Killing Dozens as Indian State Suffers Worst Outbreak in Years
https://www.medscape.com/viewarticle/958610

Sep 14th, 2021 - NEW DELHI (Reuters) - An outbreak of dengue fever is suspected of killing dozens of people in India's northern state of Uttar Pradesh since the start of September, and authorities have launched a campaign to destroy mosquito breeding grounds. Dine...

Cases Spike in LA County; 'Horrifying' Anti-Vax Cheer; FDA Probes Aduhelm Approval
https://www.medpagetoday.com/infectiousdisease/covid19/93519

Jul 12th, 2021 - Note that some links may require registration or subscription. Los Angeles County is experiencing a worrisome spike in COVID-19 cases, with thousands of new infections mainly in unvaccinated residents. (Los Angeles Times) "Horrifying." That was th...

Dengue Infections Can Be Sharply Reduced With Wolbachia Bacteria
https://www.medscape.com/viewarticle/953043

Jun 14th, 2021 - A modestly titled new study released in the New England Journal of Medicine belies the extraordinary 77% protective efficacy reported for preventing dengue infections with Wolbachia-infected Aedes aegypti mosquitoes. A cluster-randomized clinical ...

see more →

Patient Education  5 results see all →